To assess the association of compliance with treatment (medication and clinic appointments) and all-cause mortality in people with insulin-treated type 2 diabetes. Data were extracted from U.K. general practice records and included patients (Those identified as clinic nonattenders were more likely to be smokers, younger, have higher HbAMedication noncompliance and clinic nonattendance, assessed during routine care by primary care physicians or their staff, were independently associated with increased all-cause mortality in patients with type 2 diabetes receiving insulin.